J. Clancy et al., CLONING AND CHARACTERIZATION OF A NOVEL MACROLIDE EFFLUX GENE, MREA, FROM STREPTOCOCCUS-AGALACTIAE, Antimicrobial agents and chemotherapy, 41(12), 1997, pp. 2719-2723
A strain of Streptococcus agalactiae displayed resistance to 14-, 15-,
and 16-membered macrolides. In PCR assays, total genomic DNA from thi
s strain contained neither erm nor mef genes. EcoRI-digested genomic D
NA from this strain was cloned into lambda Zap II to construct a libra
ry of S. agalactiae genomic DNA. A clone, pAES63, expressing resistanc
e to erythromycin, azithromycin, and spiramycin in Escherichia coli wa
s recovered. Deletion derivatives of pAES63 which defined a functional
region on this clone that encoded resistance to 14- and 15-membered,
but not 16-membered, macrolides were produced. Studies that determined
the level of incorporation of radiolabelled erythromycin into E. coli
were consistent with the presence of a macrolide efflux determinant.
This putative efflux determinant was distinct from the recently descri
bed Mef pump in Streptococcus pyogenes and Streptococcus pneumoniae an
d from the multicomponent MsrA Pump in Staphylococcus aureus and coagu
lase-negative staphylococci. Its gene has been designated mreA (for ma
crolide resistance efflux).